OR WAIT null SECS
© 2023 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
Novartis is to purchase 25% of Alcon from majority stakeholder Nestlé, with an option to purchase Nestlé's remaining shares, which currently amount to approximately 52% of Alcon.